chitosan has been researched along with Hematoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arbel, J; Caneti, M; Erel, J; Haskia, AR; Levi, A; Mosseri, M; Neuman, Y; Reges, O; Rozenbaum, E; Sherf, M | 1 |
| Akduman, B; Aydın Mungan, N; Bektaş, S; Erol, B; Hakimolu, S; Hancı, V; Karakaya, K; Tokgöz, H | 1 |
| Körner, B; Poretti, F; Rosen, T; Vorwerk, D | 1 |
| Aimin, C; Chunlin, H; Juliang, B; Tinyin, Z; Zhichao, D | 1 |
2 trial(s) available for chitosan and Hematoma
| Article | Year |
|---|---|
USage of chitosan for Femoral (USF) haemostasis after percutaneous procedures: a comparative open label study.
Topics: Aged; Catheterization, Peripheral; Chi-Square Distribution; Chitosan; Coronary Angiography; Female; Femoral Artery; Hematoma; Hemorrhage; Hemostatic Techniques; Hemostatics; Humans; Israel; Male; Middle Aged; Pressure; Punctures; Time Factors; Treatment Outcome | 2011 |
[Chitosan pads vs. manual compression to control bleeding sites after transbrachial arterial catheterization in a randomized trial].
Topics: Angiography; Anticoagulants; Brachial Artery; Catheterization, Peripheral; Chitosan; Diabetes Complications; Female; Hematoma; Hemostatic Techniques; Hemostatics; Humans; Hypertension; Male; Risk Factors; Time Factors | 2005 |
2 other study(ies) available for chitosan and Hematoma
| Article | Year |
|---|---|
Postoperative adhesions after application of topical hemostatic agents: outcomes in a rat partial nephrectomy model.
Topics: Administration, Topical; Animals; Cellulose; Chitosan; Hematoma; Hemostasis; Hemostatic Techniques; Hemostatics; Ischemia; Kidney; Male; Nephrectomy; Oxygen; Plant Extracts; Postoperative Complications; Rats; Rats, Wistar; Tissue Adhesions; Wound Healing | 2011 |
Antibiotic loaded chitosan bar. An in vitro, in vivo study of a possible treatment for osteomyelitis.
Topics: Absorbable Implants; Animals; Anti-Bacterial Agents; Biocompatible Materials; Biopolymers; Chitin; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Desiccation; Diffusion; Drug Carriers; Drug Delivery Systems; Gentamicins; Hematoma; Osteomyelitis; Rabbits; Solvents; Tibia | 1999 |